A citation-based method for searching scientific literature

Adam D Cohen, Alfred L Garfall, Edward A Stadtmauer, J Joseph Melenhorst, Simon F Lacey, Eric Lancaster, Dan T Vogl, Brendan M Weiss, Karen Dengel, Annemarie Nelson, Gabriela Plesa, Fang Chen, Megan M Davis, Wei-Ting Hwang, Regina M Young, Jennifer L Brogdon, Randi Isaacs, Iulian Pruteanu-Malinici, Don L Siegel, Bruce L Levine, Carl H June, Michael C Milone. J Clin Invest 2019
Times Cited: 304



Michel Sadelain, Renier Brentjens, Isabelle Rivière. Cancer Discov 2013
Times Cited: 732




List of shared articles



Times cited


Controlling Cell Trafficking: Addressing Failures in CAR T and NK Cell Therapy of Solid Tumours.
Lydia G White, Hannah E Goy, Alinor J Rose, Alexander D McLellan. Cancers (Basel) 2022
2


CAR T cell therapies for patients with multiple myeloma.
Lekha Mikkilineni, James N Kochenderfer. Nat Rev Clin Oncol 2021
60

Pharmacology of Chimeric Antigen Receptor-Modified T Cells.
Edward Z Song, Michael C Milone. Annu Rev Pharmacol Toxicol 2021
3

Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7.
Christina Amatya, Melissa A Pegues, Norris Lam, Danielle Vanasse, Claudia Geldres, Stephanie Choi, Stephen M Hewitt, Steven A Feldman, James N Kochenderfer. Mol Ther 2021
21

An IMiD-inducible degron provides reversible regulation for chimeric antigen receptor expression and activity.
Seth Carbonneau, Sujata Sharma, Liaomin Peng, Vaisakh Rajan, Dominik Hainzl, Martin Henault, Chian Yang, Jacob Hale, Janine Shulok, John Tallarico,[...]. Cell Chem Biol 2021
4

Perspectives for the Use of CAR-T Cells for the Treatment of Multiple Myeloma.
Marcin Jasiński, Grzegorz W Basak, Wiesław W Jedrzejczak. Front Immunol 2021
10

Efficacy and Safety of CAR-T Therapy for Relapse or Refractory Multiple Myeloma: A systematic review and meta-analysis.
Qin Yang, Xin Li, Fangrong Zhang, Qiaohui Yang, Wen Zhou, Jing Liu. Int J Med Sci 2021
2